CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment by Lisa Scheiblecker, Karoline Kollmann, Veronika Sexl

Get full text

Preserved bevacizumab (Avastin®) eye drops for application in multidose containers – an in-vitro characterisation by Ulrike Lessiak, Tania Brandstoetter, Barbara Nell, Klara Klein, Georg Mlynek, Lukas Wimmer, Lisa Scheiblecker, Alexander Tichy, Andrea Hoelbl-Kovacic

Get full text

Cdk6’s functions are critically regulated by its unique C-terminus by Alessia Schirripa, Helge Schöppe, Sofie Nebenfuehr, Markus Zojer, Thorsten Klampfl, Valentina Kugler, Belinda S. Maw, Huriye Ceylan, Iris Z. Uras, Lisa Scheiblecker, Elisabeth Gamper, Ulrich Stelzl, Eduard Stefan, Teresa Kaserer, Veronika Sexl, Karoline Kollmann

Get full text

CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia by Lisa Scheiblecker, Thorsten Klampfl, Eszter Doma, Sofie Nebenfuehr, Omar Torres-Quesada, Sophie Strich, Gerwin Heller, Daniela Werdenich, Waltraud Tschulenk, Markus Zojer, Florian Bellutti, Alessia Schirripa, Sabine Zöchbauer-Müller, Peter Valent, Ingrid Walter, Eduard Stefan, Veronika Sexl, Karoline Kollmann

Get full text